Plain-English translation of NCT06299540 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether a personalized exercise program can help improve how you feel and your overall quality of life when you're being treated with for chronic lymphocytic leukemia. About 180 people will participate. Some will follow a guided exercise program with a trainer, while others will continue with their usual routine.
People undergoing cancer treatment often struggle with fatigue, weakness, and reduced quality of life. Researchers want to see if a structured, personalized exercise program can help counter these side effects and help patients feel better during this medication.
You likely qualify if…
You likely don't qualify if…
If you join, you'll either be in the exercise group or the standard care group. In the exercise group, you'll walk regularly and participate in two online exercise sessions per week that are customized to your fitness level by a trained instructor. The sessions will adjust based on what you can do. Both groups will answer questions about their quality of life at the beginning and throughout the study. The study continues while you're taking the medication.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
France
Sponsor
Janssen Cilag S.A.S.
Enrollment target
~180 participants
Started
May 2024
Primary completion
September 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Study Contact
Janssen Cilag S.A.S.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.